Expertise in
13
conditions

Laurent Magy

Limoges, FR 
Expertise in
13
conditions
Limoges, FR 
OverviewLocationsClinical Research

Overview

Laurent Magy practices in Limoges, France. Mr. Magy is highly rated in 13 conditions, according to our data. His top areas of expertise are Chronic Demyelinizing Neuropathy with IgM Monoclonal, Chronic Inflammatory Demyelinating Polyneuropathy, Charcot-Marie-Tooth Disease, and Chronic Polyradiculoneuritis.

His clinical research consists of co-authoring 174 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Gender
Male

Locations

Limoges, 87000, France
Other Locations
APHP, CHU de Bicêtre
Le Kremlin Bicêtre, France
Lille, France
Nimes, France
CHU Nantes
Nantes, France
Lyon, France
2 Avenue Martin Luther King, Martin-eglise, 87042, France
Tours, France
Bordeaux, France
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Longitudinal Study of Cognition in Primary Progressive Multiple Sclerosis: a Cohort Study
Longitudinal Study of Cognition in Primary Progressive Multiple Sclerosis: a Cohort Study
Enrollment Status: Active_not_recruiting
Publish Date: February 20, 2025
Intervention Type: Other, Device
Study Phase: Not Applicable
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Multicentric, Randomized, Double-blind Versus Placebo Study Evaluating the Efficacy of Treatment With Cholecalciferol (Vitamin D3) for Delaying the Diagnosis of Multiple Sclerosis (MS) After a Clinically Isolated Syndrome (CIS). Comparison of Conversion Rates After 2 Years.
Enrollment Status: Completed
Publish Date: January 12, 2024
Intervention Type: Biological, Drug, Other
Study Drugs: Vitamin D, Lumbar Puncture, Blood Sampling, Urine Samples
Study Phase: Phase 3
Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies
Characterization of Sensory Neuropathies Associated With Anti-FGFR3 Antibodies
Enrollment Status: Completed
Publish Date: February 10, 2023
Intervention Type: Other
Cortico-saving Treatments Proposed for CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Responsive to Steroids): a First Cohort
Cortico-saving Treatments Proposed for CLIPPERS (Chronic Lymphocytic Inflammation With Pontine Perivascular Responsive to Steroids): a First Cohort
Enrollment Status: Terminated
Publish Date: January 03, 2018
Intervention Type: Other
View 3 Less Clinical Trials

174 Total Publications

Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Therapeutic Management During Pregnancy and Relapse Risk in Women With Multiple Sclerosis.
Journal: JAMA neurology
Published: August 04, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Magy's expertise for a condition
ConditionClose
    View All 9 Advanced Conditions
    View All 47 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile